Cash & equivalents increased 124.0%
Cash & equivalents changed +124.0% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +124.0% from the comparable as-filed period.
Gross margin changed -541 basis points from the comparable as-filed period.
Gross profit changed +497.6% from the comparable as-filed period.
Net income changed -44.8% from the comparable as-filed period.
Operating income changed -75.2% from the comparable as-filed period.
Operating margin changed +26865 basis points from the comparable as-filed period.
Research & development changed +56.3% from the comparable as-filed period.
Revenue changed +656.9% from the comparable as-filed period.
Selling, general & administrative changed +278.2% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.